hydroxyurea has been researched along with Recrudescence in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (17.74) | 18.7374 |
| 1990's | 13 (20.97) | 18.2507 |
| 2000's | 17 (27.42) | 29.6817 |
| 2010's | 14 (22.58) | 24.3611 |
| 2020's | 7 (11.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, I; Bibi, R; Hassan, Z; Iqbal, A; Iqbal, MM; Zahoor, S | 1 |
| Adès, L; Azoulay, E; Boissel, N; Chevret, S; Fodil, S; Itzykson, R; Lengliné, E; Mariotte, E; Rabian, F; Raffoux, E; Rouzaud, C; Sébert, M; Valade, S; Zafrani, L | 1 |
| Kato, M; Kikuchi, K; Sakamoto, K; Sako, M; Shioda, Y; Takimoto, T | 1 |
| Jain, M; Kumar, N; Tripathi, AK; Verma, SP | 1 |
| Buono, A; De Blasio, G; Ielasi, A; Loffi, M; Tespili, M | 1 |
| Burnett, AL; Joice, GA; Liu, JL | 1 |
| Adams, RJ; Aldred, K; Badaloo, A; Knight-Madden, J; Lane, A; Latham, T; Rankine-Mullings, A; Reid, M; Schultz, WH; Soares, D; Taylor-Bryan, C; Ware, RE; Wisdom-Phipps, M | 1 |
| Balleari, E; Bernal, T; Beyne-Rauzy, O; Bordessoule, D; Calabuig, M; Cametti, G; Campelo, MD; Cheze, S; Cony-Makhoul, P; Dreyfus, F; Fenaux, P; Fensterl, J; Ferrero, D; Gaidano, G; Germing, U; Gioia, D; Götze, K; Guerci-Bresler, A; Hamel, JF; Kaivers, J; Kelaidi, C; Komrokji, R; Kotsianidis, I; Müller-Thomas, C; Pane, F; Park, S; Ramos, F; Roboz, GJ; Rose, C; Sanna, A; Santini, V; Sanz, GF; Sapena, R; Sekeres, MA; Stamatoullas, A; Steensma, DP; Thépot, S; Toma, A; Vey, N; Wattel, E | 1 |
| Calip, GS; Gordeuk, VR; Han, J; Nutescu, EA; Saraf, SL; Zhou, J | 1 |
| Barbui, T; De Stefano, V; Finazzi, G; Vannucchi, AM | 1 |
| Barbui, T; Betti, S; Carobbio, A; De Stefano, V; Finazzi, G; Ghirardi, A; Rossi, E; Vannucchi, AM | 1 |
| Berchie, PO; Opare-Sem, OK; Ovbiagele, B; Sarfo, FS | 1 |
| Abdullahi, SU; DeBaun, MR; Galadanci, NA; Jordan, LC; Rodeghier, M | 1 |
| Schlenk, RF; Thol, F | 1 |
| Escalante Boleas, M; Gutiérrez Macías, A; Lizarralde Palacios, E; Rámiz Martínez, M | 1 |
| Abdulkadri, A; Bortolusso Ali, S; Cunningham-Myrie, C; King, LG; Knight-Madden, J; Reid, M; Waugh, A | 1 |
| Kato, GJ; Minniti, CP | 1 |
| Arias, MV; Bonelli, Mde A; Camassa, JA; Diogo, CC; Fabretti, AK; Pereira, PM | 1 |
| Bardet, E; Benhamou, E; Bensadoun, RJ; Bourhis, J; Castaing, M; de Raucourt, D; Dolivet, G; Ferron, C; Géry, B; Grégoire, V; Hamoir, M; Janot, F; Julieron, M | 1 |
| Ali, FR; Arya, R; Edmondson, RA; Mistry, H; Patel, RK; Roberts, LN | 1 |
| Beumer, JH; Desjardins, A; Egorin, MJ; Friedman, HS; Gururangan, S; Herndon, JE; Lagattuta, TF; Reardon, DA; Salvado, AJ; Vredenburgh, JJ | 1 |
| Arisaka, O; Endoh, K; Fukushima, K; Hagisawa, S; Hayashi, Y; Kubota, T; Kurosawa, H; Kuwashima, S; Matsushita, T; Okada, Y; Okuya, M; Park, MJ; Sato, Y; Sugita, K | 1 |
| Akiyama, M; Arita, K; Kikuchi, K; Onozawa, M; Shimizu, H; Tateishi, Y | 1 |
| Ali, SB; King, L; Knight-Madden, J; Moosang, M; Reid, M | 1 |
| Cho, KH; Kim, KT; Sohn, SI | 1 |
| Almeida, A; Amrolia, PJ; Davies, SC; Roberts, IA | 1 |
| Charlanne, H; Prin, L | 1 |
| Abish, S; Albuquerque, P; Alyaarubi, S; Gale, M; Jabado, N; Krishnamoorthy, P | 1 |
| Chiba, S; Fukayama, M; Goyama, S; Inoue, M; Izutsu, K; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Noda, N; Oshima, K; Sato, T; Shoda, E; Watanabe, T | 1 |
| Bennett, CM; Chui, DH; Heeney, MM; Luo, HY; Tubman, VN | 1 |
| Bélisle, C; Busque, L; Hébert, J; Jamal, R; Lessard, MC; Levine, R; Roy, DC | 1 |
| Jacobs, C; Mead, GM | 1 |
| Bauernfeind, RA; Bauman, JL; Hartsough, N; Hasegawa, GR; Roden, R; Shulruff, S | 1 |
| Kinney, TR; Steinberg, MH; Ware, RE | 1 |
| Ring, T | 1 |
| Armitage, JO; Bierman, PJ; Gwilt, P; Kris, E; Vaughan, WP; Vose, J | 1 |
| Cinkotai, KI; Donnai, P; Kendra, J; Wood, P | 1 |
| Bundy, BN; Creasman, WT; d'Ablaing, G; Fowler, WC; Keys, HM; Mortel, R; Stehman, FB; Thomas, G | 1 |
| Ash, RC; Atkinson, K; Dicke, KA; Gale, RP; Gluckman, E; Goldman, JM; Herzig, RH; Horowitz, MM; Marmont, A; Szydlo, R | 1 |
| Feenstra, J; in 't Veld, BA; Runhaar, EA; Slappendel, AM; Stricker, BH; van Aken, J; Veen, C | 1 |
| Azuma, E; Higashigawa, M; Hirayama, M; Hori, H; Ido, M; Kawasaki, H; Sakurai, M | 1 |
| Al Dabbous, IA; Al Jam'a, AH | 1 |
| Grace, RF; Grant, J; Ravich, R; Shenfield, GM | 1 |
| Chernoff, SG; Ruiz-Argüelles, GJ; Ruiz-Delgado, GJ; Ruiz-Reyes, G | 1 |
| Akarsu, E; Bozkurt, E; Gündogdu, M; Kaya, H; Tekin, SB | 1 |
| Abhyankar, D; Advani, SH; Saikia, T; Shende, C | 1 |
| Baumgartner, RW; Boltshauser, E; Frischknecht, H; Humbert, J; Schmugge, M; Yonekawa, Y | 1 |
| Allochon, Y; Blanc, M; Evreux, JC; Gallant, C; Monier, JM; Vial, T | 1 |
| Bernardi, M; Camba, L; Pescarollo, A | 1 |
| Ackerstein, A; Cividalli, G; Gelfand, Y; Morecki, S; Slavin, S | 1 |
| Bauters, F; Cambier, N; Darre, S; Demory, JL; Gyan, E; Jude, B; Rose, C | 1 |
| Das, R; Garewal, G; Kaur, U | 1 |
| Davis, R; Irwin, L; Levin, VA; Pischer, TL; Wara, W; Wilson, CB | 1 |
| Opitz, U; Seidel, HJ | 1 |
| Nakagawa, H; Shin, KH; Tsurufuji, S | 1 |
| Bukhave, K; Lauritsen, K; Laursen, LS; Naesdal, J; Rask-Madsen, J | 1 |
| Archimbaud, E; Devaux, Y; Fiere, D; French, M; Guyotat, D; Moriceau, M; Sebban, C; Troncy, J; Viala, JJ | 1 |
| Aghai, E; Froom, P; Quitt, M | 1 |
| Daugherty, C; Fischer, TJ; Gleich, GJ; Gushurst, C; Kephart, GM | 1 |
| Berrebi, A; Varon, D; Wetzler, M | 1 |
| Crowther, D; Gasser, AB; Scarffe, JH; Steward, WP; Wagstaff, J | 1 |
| Greenwald, MA; Moschella, SL | 1 |
8 review(s) available for hydroxyurea and Recrudescence
| Article | Year |
|---|---|
Essential Thrombocythemia Presenting with Recurrent Priapism: A Case Report and Review of Literature.
Topics: Adult; Antineoplastic Agents; Aspirin; Cytoreduction Surgical Procedures; Humans; Hydroxyurea; Male; Platelet Aggregation Inhibitors; Priapism; Recurrence; Thrombocythemia, Essential | 2020 |
Medical treatment of recurrent ischaemic priapism: a review of current molecular therapeutics and a new clinical management paradigm.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-Agonists; Algorithms; Anemia, Sickle Cell; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antisickling Agents; Humans; Hydroxyurea; Ischemia; Ketoconazole; Male; P-Selectin; Penile Erection; Phosphodiesterase 5 Inhibitors; Priapism; Recurrence | 2021 |
Gemtuzumab ozogamicin in acute myeloid leukemia revisited.
Topics: Age Factors; Aminoglycosides; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Gemtuzumab; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Recurrence; Treatment Failure | 2014 |
[Fever induced by hydroxycarbamide].
Topics: Aged; Fever; Humans; Hydroxyurea; Male; Myalgia; Recurrence; Thrombocythemia, Essential | 2015 |
Critical Reviews: How we treat sickle cell patients with leg ulcers.
Topics: Anemia, Sickle Cell; Drug Therapy, Combination; Erythropoietin; Humans; Hydroxyurea; Leg Ulcer; Recurrence; Treatment Outcome; Wound Healing | 2016 |
Therapeutic challenges in childhood sickle cell disease. Part 2: a problem-orientated approach.
Topics: Anemia, Sickle Cell; Antisickling Agents; Bone Marrow Transplantation; Central Nervous System Diseases; Chest Pain; Child; Constriction, Pathologic; Erythrocyte Transfusion; Humans; Hydroxyurea; Recurrence; Stroke; Syndrome; Vascular Diseases | 2003 |
[Treatment of hypereosinophilia].
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Benzamides; Chronic Disease; Cyclosporins; Drug Resistance; Eosinophilia; Glucocorticoids; Humans; Hydroxyurea; Imatinib Mesylate; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Myeloproliferative Disorders; Parasitic Diseases; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Recurrence; Time Factors | 2006 |
Changing role of chemotherapy in treatment of head and neck cancer.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Methotrexate; Recurrence | 1982 |
9 trial(s) available for hydroxyurea and Recrudescence
| Article | Year |
|---|---|
Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.
Topics: Adolescent; Anemia, Sickle Cell; Antisickling Agents; Blood Flow Velocity; Cerebrovascular Circulation; Cerebrovascular Disorders; Child; Child, Preschool; Female; Humans; Hydroxyurea; Incidence; Jamaica; Magnetic Resonance Imaging; Male; Neuroimaging; Prospective Studies; Recurrence; Single-Blind Method; Stroke; Ultrasonography, Doppler, Transcranial | 2021 |
Stroke Recurrence in Nigerian Children With Sickle Cell Disease: Evidence for a Secondary Stroke Prevention Trial.
Topics: Adolescent; Anemia, Sickle Cell; Antisickling Agents; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Hydroxyurea; Infant; Male; Nigeria; Prospective Studies; Recurrence; Secondary Prevention; Stroke | 2019 |
Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Neoplasm Metastasis; Postoperative Period; Recurrence; Salvage Therapy; Treatment Outcome | 2008 |
Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Brain Neoplasms; Female; Glioblastoma; Glioma; Humans; Hydroxyurea; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Middle Aged; Phthalazines; Piperazines; Pyridines; Pyrimidines; Recurrence; Treatment Outcome | 2009 |
Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mouth Mucosa; Recurrence; Remission Induction; Risk Factors; Stomatitis; Survival Analysis | 1995 |
Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Cause of Death; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Hydroxyurea; Life Tables; Middle Aged; Misonidazole; Recurrence; Survival Analysis; Uterine Cervical Neoplasms | 1993 |
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase.
Topics: Actuarial Analysis; Bone Marrow Transplantation; Busulfan; Follow-Up Studies; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Probability; Recurrence; Survival Analysis; Time Factors | 1993 |
Preliminary results of a phase III comparison study of BCNU, hydroxyurea and radiation to BCNU and radiation.
Topics: Brain Neoplasms; Carmustine; Clinical Trials as Topic; Drug Therapy, Combination; Glioblastoma; Glioma; Humans; Hydroxyurea; Recurrence; Time Factors | 1979 |
Treatment of relapsed non-Hodgkin's lymphoma with a combination of hydroxyurea, ifosfamide, and etoposide.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Etoposide; Female; Humans; Hydroxyurea; Ifosfamide; Lymphoma; Male; Middle Aged; Recurrence | 1985 |
45 other study(ies) available for hydroxyurea and Recrudescence
| Article | Year |
|---|---|
Hydroxyurea- a cost effective treatment in developing countries for Atypical Chronic Myeloid Leukemia (aCML): Case Report of Two Patients.
Topics: Aged; Cost-Benefit Analysis; Developing Countries; Humans; Hydroxyurea; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Pain; Recurrence | 2022 |
Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications.
Topics: Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Proportional Hazards Models; Recurrence; Remission Induction; Retrospective Studies | 2022 |
Pilot study to estimate the safety and effectiveness of hydroxyurea and methotrexate recurrent langerhans cell histiocytosis (LCH-HU-pilot).
Topics: Histiocytosis, Langerhans-Cell; Humans; Hydroxyurea; Methotrexate; Pilot Projects; Recurrence | 2022 |
Intracoronary cangrelor administration-assisted primary percutaneous coronary intervention in a patient with essential thrombocythemia and recurrent ST-segment elevation myocardial infarction.
Topics: Adenosine Monophosphate; Adult; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Drug-Eluting Stents; Humans; Hydroxyurea; Infusions, Intravenous; Male; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Recurrence; ST Elevation Myocardial Infarction; Thrombocythemia, Essential; Treatment Outcome | 2020 |
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.
Topics: Aged; Aged, 80 and over; Anemia; Antilymphocyte Serum; Antineoplastic Agents; Arsenic; Azacitidine; Chromosome Deletion; Chromosomes, Human, Pair 5; Cyclosporine; Cytarabine; Decitabine; Disease Progression; Enzyme Inhibitors; Erythrocyte Transfusion; Female; Hematinics; Humans; Hydroxyurea; Immunologic Factors; Lenalidomide; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Recurrence; Retreatment; Retrospective Studies; Risk Factors; Survival Rate; Thalidomide; Treatment Failure; Tretinoin; Valproic Acid | 2017 |
Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6-year population-based cohort study.
Topics: Adolescent; Adult; Age Distribution; Aged; Anemia, Sickle Cell; Antisickling Agents; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydroxyurea; Infant; Infant, Newborn; Male; Medication Adherence; Middle Aged; Patient Readmission; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
Targeting myeloid cells to prevent recurrent stroke in general population: the lesson of hydroxyurea in myeloproliferative neoplasms.
Topics: Humans; Hydroxyurea; Leukocyte Count; Myeloid Cells; Myeloproliferative Disorders; Recurrence; Stroke; Treatment Outcome | 2018 |
Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Hydroxyurea; Incidence; Male; Middle Aged; Myeloproliferative Disorders; Recurrence; Thrombosis; Treatment Outcome; Venous Thrombosis; Young Adult | 2018 |
Recurrent Stroke in a Ghanaian Patient With Polycythemia.
Topics: Aphasia, Broca; Aspirin; Clopidogrel; Ghana; Humans; Hydroxyurea; Infarction, Middle Cerebral Artery; Male; Medication Adherence; Middle Aged; Paresis; Phlebotomy; Platelet Aggregation Inhibitors; Polycythemia; Recurrence; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Hydroxyurea use in prevention of stroke recurrence in children with sickle cell disease in a developing country: A cost effectiveness analysis.
Topics: Anemia, Sickle Cell; Antisickling Agents; Child; Cost-Benefit Analysis; Developing Countries; Female; Humans; Hydroxyurea; Jamaica; Male; Recurrence; Stroke | 2015 |
Diagnosis and Treatment of Primary Erythrocytosis in a Dog: A Case Report.
Topics: Animals; Antineoplastic Agents; Diagnosis, Differential; Dog Diseases; Dogs; Euthanasia, Animal; Fatal Outcome; Fluid Therapy; Hydroxyurea; Male; Phlebotomy; Polycythemia Vera; Recurrence | 2015 |
Recurrent refractory arterial thromboembolism associated with the Janus kinase 2 V617F mutation.
Topics: Anticoagulants; Arterial Occlusive Diseases; Humans; Hydroxyurea; Janus Kinase 2; Male; Middle Aged; Mutation; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Radiography, Interventional; Recurrence; Thromboembolism; Treatment Failure; Vascular Surgical Procedures | 2009 |
JAK2V617F mutation-positive childhood essential thrombocythemia associated with cerebral venous sinus thrombosis.
Topics: Aspirin; Child; Clone Cells; Cytotoxins; Diagnosis, Differential; Female; Headache; Humans; Hydroxyurea; Janus Kinase 2; Nausea; Platelet Aggregation Inhibitors; Recurrence; Sinus Thrombosis, Intracranial; Supratentorial Neoplasms; Thrombocythemia, Essential; Thrombophilia | 2009 |
Recurrence of hydroxyurea-induced leg ulcer after discontinuation of treatment.
Topics: Aged, 80 and over; Biopsy; Humans; Hydroxyurea; Leg Ulcer; Male; Polycythemia Vera; Recurrence; Treatment Outcome; Wound Healing | 2011 |
Stroke recurrence in children with sickle cell disease treated with hydroxyurea following first clinical stroke.
Topics: Anemia, Sickle Cell; Child; Cohort Studies; Female; Humans; Hydroxyurea; Male; Recurrence; Stroke | 2011 |
Cerebral infarct in a patient with a history of systemic arterial and venous thrombosis from essential thrombocythemia.
Topics: Arterial Occlusive Diseases; Biopsy; Bone Marrow Examination; Cerebral Angiography; Cerebral Infarction; Diffusion Magnetic Resonance Imaging; Humans; Hydroxyurea; Infarction, Posterior Cerebral Artery; Magnetic Resonance Angiography; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Count; Recurrence; Risk Factors; Splenic Infarction; Thalamus; Thrombocythemia, Essential; Thrombosis; Tomography, X-Ray Computed; Venous Thrombosis | 2012 |
Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
Topics: Adenoma; Adolescent; Analgesics, Opioid; Anemia, Sickle Cell; Arthralgia; Back Pain; Bone Resorption; Diagnosis, Differential; Emergency Service, Hospital; Female; Humans; Hydroxyurea; Hypercalcemia; Hyperparathyroidism; Knee Joint; Parathyroid Hormone; Parathyroid Neoplasms; Recurrence; Treatment Refusal; Vascular Diseases | 2006 |
Early relapse of JAK2 V617F-positive chronic neutrophilic leukemia with central nervous system infiltration after unrelated bone marrow transplantation.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Bone Marrow Transplantation; Brain; Chromosome Inversion; Chromosomes, Human, Pair 9; Combined Modality Therapy; Cytidine Monophosphate; Dysarthria; Fatal Outcome; Humans; Hydroxyurea; Hyperesthesia; Janus Kinase 2; Leukemia, Neutrophilic, Chronic; Leukemic Infiltration; Male; Middle Aged; Neoplasm Proteins; Recurrence; Transplantation, Homologous | 2007 |
Sickle cell disease caused by Hb S/Québec-CHORI: treatment with hydroxyurea and response.
Topics: Abdominal Pain; Acute Disease; Anemia, Sickle Cell; Cholecystectomy; Cholecystitis; Exchange Transfusion, Whole Blood; Female; Follow-Up Studies; Globins; Hemoglobin, Sickle; Hemoglobins, Abnormal; Heterozygote; Humans; Hydroxyurea; Infant, Newborn; Pain; Pleural Effusion; Recurrence; Respiratory Distress Syndrome; Sickle Cell Trait | 2007 |
Evidence suggesting the presence of a stem cell clone anteceding the acquisition of the JAK2-V617F mutation.
Topics: Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Janus Kinase 2; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Recurrence; Transplantation Chimera; Transplantation, Homologous | 2008 |
Fever caused by hydroxyurea.
Topics: Aspirin; Female; Fever; Humans; Hydroxyurea; Middle Aged; Psoriasis; Recurrence | 1981 |
Hydroxyurea: an alternative to transfusion therapy for stroke in sickle cell anemia.
Topics: Adult; Anemia, Sickle Cell; Blood Group Incompatibility; Blood Transfusion; Cerebrovascular Disorders; Female; Ferritins; Humans; Hydroxyurea; Male; Recurrence | 1995 |
Hydroxyurea in essential thrombocytosis.
Topics: Data Interpretation, Statistical; Humans; Hydroxyurea; Multivariate Analysis; Recurrence; Thrombocytosis; Thrombosis | 1995 |
Pregnancy after treatment with hydroxyurea in a patient with primary thrombocythaemia and a history of recurrent abortion.
Topics: Abortion, Habitual; Adult; Blood Platelets; Female; Humans; Hydroxyurea; Pregnancy; Pregnancy Complications, Hematologic; Recurrence; Thrombocythemia, Essential | 1994 |
Fever attributed to the use of hydroxyurea.
Topics: Aged; Antineoplastic Agents; Female; Fever; Humans; Hydroxyurea; Male; Recurrence; Thrombocytosis | 1997 |
Salvage therapy for relapsed or refractory childhood acute lymphocytic leukemia by alternative administration a lymphoid- and myeloid-directed chemotherapeutic regimen consisting of dual modulation of ara-C, hydroxyurea, and etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Fever; Gastrointestinal Diseases; Humans; Hydrocortisone; Hydroxyurea; Leucovorin; Male; Methotrexate; Mitoxantrone; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Treatment Outcome | 1997 |
Hydroxyurea in the treatment of sickle cell associated priapism.
Topics: Adult; Antisickling Agents; Humans; Hydroxyurea; Male; Priapism; Recurrence; Sickle Cell Trait | 1998 |
Recurrent pyrexia, cough and dyspnoea with hydroxyurea.
Topics: Cough; Dyspnea; Fever; Humans; Hydroxyurea; Male; Middle Aged; Polycythemia Vera; Recurrence | 1998 |
Anagrelide-induced relapse of a hydroxyurea-induced leg ulcer in a patient with primary thrombocythemia.
Topics: Aged; Antineoplastic Agents; Female; Fibrinolytic Agents; Humans; Hydroxyurea; Leg Ulcer; Platelet Aggregation Inhibitors; Quinazolines; Recurrence; Thrombocythemia, Essential | 1998 |
Essential thrombocythemia and recurrent myocardial infarction.
Topics: Angina, Unstable; Female; Humans; Hydroxyurea; Middle Aged; Myocardial Infarction; Platelet Count; Recurrence; Thrombocythemia, Essential | 2000 |
Hydroxyurea induced leg ulcers.
Topics: Adult; Antineoplastic Agents; Fatal Outcome; Female; Humans; Hydroxyurea; Leg Ulcer; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Recurrence; Splenomegaly | 2000 |
Stroke in hemoglobin (SD) sickle cell disease with moyamoya: successful hydroxyurea treatment after cerebrovascular bypass surgery.
Topics: Anemia, Sickle Cell; Aphasia; Blood Flow Velocity; Blood Transfusion; Brain Damage, Chronic; Brain Ischemia; Carotid Stenosis; Cerebral Revascularization; Cerebrovascular Circulation; Child; Christianity; Combined Modality Therapy; Fetal Hemoglobin; Follow-Up Studies; Humans; Hydroxyurea; Male; Moyamoya Disease; Paresis; Recurrence; Treatment Refusal | 2001 |
[Drug-induced fever caused by hydroxyurea. Apropos of 3 new cases].
Topics: Aged; Antineoplastic Agents; Enzyme Inhibitors; Female; Fever; Humans; Hydroxyurea; Male; Middle Aged; Pulmonary Fibrosis; Recurrence; Thrombocythemia, Essential | 1998 |
Complete haematological response with granulocyte colony stimulating factor (G-CSF) and hydroxyurea in relapsed acute myeloid leukaemia (AML) of the elderly.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Granulocyte Colony-Stimulating Factor; Humans; Hydroxyurea; Leukemia, Myelomonocytic, Acute; Male; Recurrence; Remission Induction; Treatment Outcome | 2001 |
Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes.
Topics: Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Child; Combined Modality Therapy; Female; Haplotypes; Humans; Hydroxyurea; Immunologic Factors; Immunotherapy, Adoptive; Interferon alpha-2; Interferon-alpha; Isoantigens; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Activation; Lymphocyte Transfusion; Recombinant Proteins; Recurrence; Remission Induction; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Acute priapism in a patient with unstable hemoglobin Perth and Factor V Leiden under effective oral anticoagulant therapy.
Topics: Activated Protein C Resistance; Adult; Anticoagulants; Cell Adhesion; Erythrocyte Membrane; Etilefrine; Factor V; Hemoglobins, Abnormal; Humans; Hydroxyurea; Male; Priapism; Pulmonary Embolism; Recurrence; Splenectomy; Thrombocytosis; Thrombophilia; Vasoconstrictor Agents | 2001 |
Splenectomy in a case of splenic vein thrombosis unmasks essential thrombocythemia.
Topics: Adult; Hematemesis; Humans; Hydroxyurea; Hypertension, Portal; Ischemic Attack, Transient; Male; Platelet Count; Recurrence; Splenectomy; Splenic Vein; Splenomegaly; Thrombocythemia, Essential; Venous Thrombosis | 2002 |
Hematopoietic stem cells in Friend murine leukemia virus-infected mice undergoing chemotherapy: remission and relapse of erythropoietin-independent erythropoiesis induced by hydroxyurea.
Topics: Animals; Cell Survival; Colony-Forming Units Assay; Erythropoiesis; Erythropoietin; Female; Friend murine leukemia virus; Hematopoietic Stem Cells; Hydroxyurea; Leukemia, Experimental; Mice; Mice, Inbred DBA; Recurrence; Remission, Spontaneous | 1979 |
Inhibition by hydroxyurea of the rebound of granulomatous inflammation following withdrawal of glucocorticoid therapy.
Topics: Animals; DNA; Granuloma; Hydrocortisone; Hydroxyurea; Male; Rats; Recurrence; Time Factors | 1975 |
Selective 5-lipoxygenase inhibition in ulcerative colitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arachidonate Lipoxygenases; Colitis, Ulcerative; Dialysis; Dinoprostone; Drug Evaluation; Humans; Hydroxyurea; Leukotriene B4; Lipoxygenase Inhibitors; Middle Aged; Recurrence; Time Factors | 1990 |
Phase II trial of plicamycin and hydroxyurea in acute myelogenous leukemia.
Topics: Bone Marrow; Drug Evaluation; Drug Resistance; Drug Synergism; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Plicamycin; Recurrence; Remission Induction; Time Factors | 1989 |
The mean leukocyte myeloperoxidase index in hematological patients.
Topics: Hematologic Diseases; Hospitalization; Humans; Hydroxyurea; Leukocytes; Lymphoma; Lymphoma, Non-Hodgkin; Peroxidase; Recurrence; Reference Values | 1989 |
Systemic vasculitis associated with eosinophilia and marked degranulation of tissue eosinophils.
Topics: Blood Proteins; Child; Diagnosis, Differential; Eosinophil Granule Proteins; Eosinophilia; Eosinophils; Female; Humans; Hydroxyurea; Lip; Lung; Methylprednisolone; Parotid Gland; Prognosis; Recurrence; Ribonucleases; Skin; Submandibular Gland; Trachea; Vasculitis | 1988 |
Hypereosinophilic syndrome associated with polycythemia vera.
Topics: Eosinophilia; Female; Humans; Hydroxyurea; Middle Aged; Polycythemia Vera; Primary Myelofibrosis; Recurrence; Syndrome | 1986 |
Psoriasis with hydroxyurea. An 18-month study of 60 patients.
Topics: Adult; Aged; Anemia; Chemical and Drug Induced Liver Injury; Drug Resistance; Female; Humans; Hydroxyurea; Leukopenia; Liver; Male; Middle Aged; Psoriasis; Recurrence; Thrombocytopenia; Time Factors | 1973 |